NEVRO CORP - NOTE 1.750% 6/0

CUSIP: 64157FAA1

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Debt / NOTE 1.750% 6/0
Market price (% of par)
121.35%
Total 13F principal
$178,572,004
Principal change
+$1,958,004
Total reported market value
$216,989,004
Number of holders
21
Value change
+$5,260,565
Number of buys
9
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 64157FAA1?
CUSIP 64157FAA1 identifies 64157FAA1 - NEVRO CORP - NOTE 1.750% 6/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEVRO CORP - NOTE 1.750% 6/0 as of Q1 2017

As of 31 Mar 2017, NEVRO CORP - NOTE 1.750% 6/0 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $178,572,004 in principal (par value) of the bond. The largest 10 bondholders included OAKTREE CAPITAL MANAGEMENT LP, DEERFIELD MANAGEMENT CO, Allianz Asset Management GmbH, WOLVERINE ASSET MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, LORD, ABBETT & CO. LLC, CITADEL ADVISORS LLC, CAMDEN ASSET MANAGEMENT L P /CA, Nicholas Investment Partners, LP, and Invesco Ltd.. This page lists 21 institutional bondholders reporting positions for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.